{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:17:07Z","timestamp":1790900227478,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Phenotypic drug susceptibility testing (DST) is considered the gold standard for detecting linezolid (LZD) resistance in\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      (MTB), but it is time-consuming. Nanopore sequencing offers a potentially faster alternative approach. This study evaluated the agreement between phenotypically detected LZD resistance and mutations in the rrl and rplC genes of MTB isolates using nanopore sequencing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Consecutive drug-resistant MTB isolates from pulmonary samples collected in 2021 underwent liquid culture (LC) DST for LZD. All resistant isolates and an equal number of susceptible isolates were subjected to targeted sequencing of the rrl and rplC genes using nanopore technology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Sequencing identified a C154R mutation in the rplC gene in only one LZD-resistant isolate. No mutations were detected in the rrl gene. The agreement between sequencing and LC-DST for detecting LZD resistance was poor (Cohen\u2019s kappa: 0.03571, 95% confidence interval [CI]: \u22120.034\u20130.105). Additionally, no significant association was found between LZD resistance and clinical or microbiological outcomes at 6-month follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study revealed a considerable discrepancy between phenotypic and genotypic detection of LZD resistance in MTB. Further research is needed to better understand the genetic mechanisms underlying LZD resistance and to develop reliable molecular diagnostics for rapid resistance detection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijmy.ijmy_139_24","type":"journal-article","created":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T16:00:44Z","timestamp":1726416044000},"page":"331-336","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Agreement between Phenotypically Detected Linezolid Resistance and Mutations in rrl and rplC Genes of Mycobacterium tuberculosis Isolates Using Nanopore Sequencing"],"prefix":"10.4103","volume":"13","author":[{"given":"Senjuti","family":"Sengupta","sequence":"first","affiliation":[{"name":"Department of Microbiology, KGMU, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parul","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Microbiology, KGMU, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Ratnam","sequence":"additional","affiliation":[{"name":"Department of Microbiology, KGMU, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhoopendra Kumar","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Microbiology, KGMU, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urmila","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Microbiology, KGMU, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Microbiology, KGMU, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Paliwal","sequence":"additional","affiliation":[{"name":"Department of Microbiology, KGMU, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3195-0220","authenticated-orcid":false,"given":"Amita","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Microbiology, KGMU, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,14]]},"reference":[{"key":"R1-20241212","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijmyco.2013.09.002","article-title":"Multidrug-resistant tuberculosis treatment with linezolid-containing regimen","volume":"2","author":"Farshidpour","year":"2013","journal-title":"Int J Mycobacteriol"},{"key":"R2-20241212","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/jac\/dkz206","article-title":"Linezolid resistance in patients with drug-resistant TB and treatment failure in South Africa","volume":"74","author":"Wasserman","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"R3-20241212","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa2119430","article-title":"Bedaquiline-pretomanid-linezolid regimens for drug-resistant tuberculosis","volume":"387","author":"Conradie","year":"2022","journal-title":"N Engl J Med"},{"key":"R4-20241212","article-title":"A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamides","author":"Ali","year":"2024","journal-title":"BioRxiv"},{"key":"R5-20241212","doi-asserted-by":"crossref","first-page":"e058606","DOI":"10.1136\/bmjopen-2021-058606","article-title":"Randomised trial to evaluate the effectiveness and safety of varying doses of linezolid with bedaquiline and pretomanid in adults with pre-extensively drug-resistant or treatment intolerant\/non-responsive multidrug-resistant pulmonary tuberculosis: Study protocol","volume":"12","author":"Padmapriyadarsini","year":"2022","journal-title":"BMJ Open"},{"key":"R6-20241212","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/ijmr.IJMR_1168_19","article-title":"Linezolid resistance in Mycobacterium tuberculosis isolates at a tertiary care centre in Mumbai, India","volume":"154","author":"Nambiar","year":"2021","journal-title":"Indian J Med Res"},{"key":"R7-20241212","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12866-022-02622-x","article-title":"Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confirmed XDR-TB clinical isolates","volume":"22","author":"Singh","year":"2022","journal-title":"BMC Microbiol"},{"key":"R9-20241212","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1186\/s12879-023-08629-7","article-title":"Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia","volume":"23","author":"V\u012bksna","year":"2023","journal-title":"BMC Infect Dis"},{"key":"R12-20241212","doi-asserted-by":"crossref","first-page":"e0061021","DOI":"10.1128\/Spectrum.00610-21","article-title":"A rapid drug resistance genotyping workflow for Mycobacterium tuberculosis, using targeted isothermal amplification and nanopore sequencing","volume":"9","author":"Gliddon","year":"2021","journal-title":"Microbiol Spectr"},{"key":"R13-20241212","doi-asserted-by":"crossref","first-page":"7588033","DOI":"10.1155\/2022\/7588033","article-title":"Rapid identification of drug-resistant tuberculosis genes using direct PCR amplification and oxford nanopore technology sequencing","volume":"2022","author":"Zhao","year":"2022","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"R14-20241212","article-title":"Guidelines for Programmatic Management of Drug Resistant Tuberculosis, National TB Elimination Programme, Central TB division, Ministry of Health and Family Welfare, Government of India, New Delhi"},{"key":"R15-20241212","first-page":"CD012836","article-title":"Linezolid for drug-resistant pulmonary tuberculosis","volume":"3","author":"Singh","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R16-20241212","doi-asserted-by":"crossref","first-page":"655653","DOI":"10.3389\/fmicb.2021.655653","article-title":"Low rate of acquired linezolid resistance in multidrug-resistant tuberculosis treated with bedaquiline-linezolid combination","volume":"12","author":"Du","year":"2021","journal-title":"Front Microbiol"},{"key":"R17-20241212","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41564-022-01130-y","article-title":"CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis","volume":"7","author":"Li","year":"2022","journal-title":"Nat Microbiol"},{"key":"R18-20241212","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/ph16060784","article-title":"Mechanisms of linezolid resistance in mycobacteria","volume":"16","author":"Gan","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"R19-20241212","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/ijmy.ijmy_101_23","article-title":"Whole-genome sequencing reveals genotypic resistance in phenotypically susceptible Mycobacterium tuberculosis clinical isolates","volume":"12","author":"Hasan","year":"2023","journal-title":"Int J Mycobacteriol"},{"key":"R20-20241212","first-page":"294","article-title":"Fluoroquinolone resistance mutations among Mycobacterium tuberculosis and their interconnection with treatment outcome","volume":"12","author":"Dixit","year":"2023","journal-title":"Int J Mycobacteriol"},{"key":"R21-20241212","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4103\/ijmy.ijmy_187_22","article-title":"Antibiotic resistance acquisition versus primary transmission in the presentation of extensively drug-resistant tuberculosis","volume":"11","author":"O\u2019Toole","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"R22-20241212","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/ijmy.ijmy_231_21","article-title":"Anemia related to linezolid-based combination regimen in drug-resistant tuberculosis","volume":"11","author":"Putra","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"R23-20241212","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/ijmy.ijmy_88_23","article-title":"Safety of antituberculosis agents used for multidrug-resistant tuberculosis among patients attending the Jamot Hospital of Yaounde, Cameroon","volume":"12","author":"Mpoh","year":"2023","journal-title":"Int J Mycobacteriol"},{"key":"R24-20241212","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4103\/ijmy.ijmy_159_22","article-title":"Middlebrook 7h11 reduces invalid results and turnaround time of phenotypic drug-susceptibility testing of M. tuberculosis","volume":"11","author":"Rupasinghe","year":"2022","journal-title":"Int J Mycobacteriol"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_139_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:43:35Z","timestamp":1787773415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_139_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_139_24","relation":{},"ISSN":["2212-5531","2212-554X"],"issn-type":[{"value":"2212-5531","type":"print"},{"value":"2212-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"2024-05-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}